Purely as a public relations matter, I have to wonder if it's wise to question if the B sample is "going to be fair" before it's even made public. Doing so makes it appear as if he already knows what the result will likely be and it's not going to be good for him. That's doper talk. It seems to me that if you're going to "pre-characterize" the result of the B sample - and I'm not suggesting that it's a good idea - it should be in the opposite direction: "I trust in the process and that the B sample will exonerate me." If the result comes back negative you're good. If it comes back positive, then you can begin attacking the system.
As it is, Bol loses either way. A positive B sample results in a suspension and a negative B sample will be tainted by Bol's own characterization of the process.